➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

McKesson
Johnson and Johnson
McKinsey
Moodys
Baxter
Medtronic

Last Updated: June 13, 2021

DrugPatentWatch Database Preview

Medroxyprogesterone acetate - Generic Drug Details

« Back to Dashboard

What are the generic drug sources for medroxyprogesterone acetate and what is the scope of patent protection?

Medroxyprogesterone acetate is the generic ingredient in seven branded drugs marketed by Pfizer, Amphastar Pharms Inc, Cipla, Mylan Labs Ltd, Sandoz Inc, Sun Pharm, Teva Pharms Usa, Amarin Pharms, Solvay, Esi , Barr, Duramed Pharms Barr, and Upsher Smith Labs, and is included in twenty-one NDAs. Additional information is available in the individual branded drug profile pages.

There are twenty drug master file entries for medroxyprogesterone acetate. Twenty-three suppliers are listed for this compound.

Drug Prices for medroxyprogesterone acetate

See drug prices for medroxyprogesterone acetate

Recent Clinical Trials for medroxyprogesterone acetate

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Assiut UniversityN/A
Teva Branded Pharmaceutical Products R&D, Inc.Phase 1
Casa di Cura Privata Villa MafaldaPhase 4

See all medroxyprogesterone acetate clinical trials

Pharmacology for medroxyprogesterone acetate
Drug ClassProgestin
Medical Subject Heading (MeSH) Categories for medroxyprogesterone acetate

US Patents and Regulatory Information for medroxyprogesterone acetate

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Cipla MEDROXYPROGESTERONE ACETATE medroxyprogesterone acetate INJECTABLE;INJECTION 210335-001 Jan 25, 2019 DISCN No No   Get Started Free   Get Started Free   Get Started Free
Esi CYCRIN medroxyprogesterone acetate TABLET;ORAL 081240-001 Oct 30, 1992 DISCN No No   Get Started Free   Get Started Free   Get Started Free
Pfizer DEPO-SUBQ PROVERA 104 medroxyprogesterone acetate INJECTABLE;SUBCUTANEOUS 021583-001 Dec 17, 2004 RX Yes Yes   Get Started Free   Get Started Free   Get Started Free
Pfizer PROVERA medroxyprogesterone acetate TABLET;ORAL 011839-004 Approved Prior to Jan 1, 1982 AB RX Yes Yes   Get Started Free   Get Started Free   Get Started Free
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Expired US Patents for medroxyprogesterone acetate

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Pfizer DEPO-PROVERA medroxyprogesterone acetate INJECTABLE;INJECTION 012541-002 Approved Prior to Jan 1, 1982   Get Started Free   Get Started Free
Pfizer DEPO-SUBQ PROVERA 104 medroxyprogesterone acetate INJECTABLE;SUBCUTANEOUS 021583-001 Dec 17, 2004   Get Started Free   Get Started Free
Pfizer DEPO-PROVERA medroxyprogesterone acetate INJECTABLE;INJECTION 012541-003 Approved Prior to Jan 1, 1982   Get Started Free   Get Started Free
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >Patent No. >Patent Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

McKinsey
Boehringer Ingelheim
McKesson
Dow
AstraZeneca
Johnson and Johnson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.